Hair loss is a reported side effect for some patients using glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound). According to the American Academy of Dermatology, rapid weight loss—rather than the medication itself—is the most common clinical trigger for a temporary shedding condition known as telogen effluvium.
Why does hair loss occur during weight loss?
Hair shedding associated with weight loss is typically a physiological response to physical stress on the body. When a person loses weight rapidly, the body may redirect energy and nutrients away from "non-essential" functions like hair growth to support vital organ systems.
This process, called telogen effluvium, occurs when a significant number of hair follicles are pushed prematurely into the resting (telogen) phase of the hair growth cycle. According to the Cleveland Clinic, this usually manifests as noticeable thinning or shedding approximately three to six months after the stressful event—such as rapid weight loss—has occurred. Because the hair loss is reactive, it is generally temporary, and hair regrowth typically begins once the body’s nutritional status stabilizes and the weight loss plateaus.
How do GLP-1 medications contribute to this process?
While clinical trials for drugs like semaglutide and tirzepatide have listed alopecia as an adverse event, the mechanism is likely indirect. The U.S. Food and Drug Administration (FDA) prescribing information for Wegovy notes that hair loss was reported in clinical studies, though it remains categorized as a less common side effect.
Medical experts often distinguish between drug-induced toxicity—where the chemical itself damages the hair follicle—and the metabolic consequences of the medication. Because GLP-1 agonists cause significant appetite suppression and weight loss, patients may inadvertently consume fewer calories or lower amounts of essential nutrients, such as protein, iron, zinc, and biotin. This nutritional deficit can exacerbate the shedding process.
How can patients manage or prevent hair thinning?
Preventing hair loss during medical weight loss centers on maintaining nutritional balance and avoiding overly aggressive weight reduction.
- Prioritize Protein: Protein is the primary building block of hair. Ensuring adequate intake, as recommended by a registered dietitian or physician, is essential for maintaining follicle health.
- Monitor Nutrient Levels: Deficiencies in iron, vitamin D, and zinc are known contributors to hair shedding. Blood tests can help identify if supplementation is necessary.
- Gradual Weight Loss: The Centers for Disease Control and Prevention (CDC) generally recommends a weight loss rate of one to two pounds per week. Rapid, extreme caloric restriction increases the likelihood of telogen effluvium.
- Consult a Physician: If hair loss becomes persistent or severe, it is important to consult a healthcare provider to rule out other underlying conditions, such as thyroid dysfunction or hormonal imbalances, which can also cause hair thinning.
When should a patient seek medical advice?
Most cases of telogen effluvium resolve on their own without specific treatment. However, patients should consult their prescribing physician if they notice:
- Patches of hair loss or circular bald spots.
- Scalp irritation, burning, or itching.
- Shedding that continues long after weight loss has stabilized.
- Hair loss accompanied by fatigue, cold intolerance, or other systemic symptoms.
A doctor can determine if the hair loss is related to the medication, nutritional deficiencies, or an unrelated dermatological condition requiring specific intervention.